[go: up one dir, main page]

WO2005058889A3 - Biological active blood serum obtained by electrostimulation - Google Patents

Biological active blood serum obtained by electrostimulation Download PDF

Info

Publication number
WO2005058889A3
WO2005058889A3 PCT/EP2004/014510 EP2004014510W WO2005058889A3 WO 2005058889 A3 WO2005058889 A3 WO 2005058889A3 EP 2004014510 W EP2004014510 W EP 2004014510W WO 2005058889 A3 WO2005058889 A3 WO 2005058889A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood serum
electrostimulation
biological active
serum obtained
active blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2004/014510
Other languages
French (fr)
Other versions
WO2005058889A2 (en
Inventor
Vitali A Shestakov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Owen Holding Ltd
Original Assignee
Owen Holding Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2003/014578 external-priority patent/WO2005058333A1/en
Priority to BRPI0417797-5A priority Critical patent/BRPI0417797A/en
Priority to CN2004800376828A priority patent/CN1893961B/en
Priority to US10/581,420 priority patent/US20070110817A1/en
Priority to JP2006544384A priority patent/JP2007514706A/en
Priority to EP04804108A priority patent/EP1699470A2/en
Application filed by Owen Holding Ltd filed Critical Owen Holding Ltd
Priority to AU2004299279A priority patent/AU2004299279B2/en
Priority to CA002546979A priority patent/CA2546979A1/en
Publication of WO2005058889A2 publication Critical patent/WO2005058889A2/en
Publication of WO2005058889A3 publication Critical patent/WO2005058889A3/en
Priority to IL176343A priority patent/IL176343A0/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/141—Feedstock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a method for preparing a blood serum product, the blood serum product and a pharmaceutical composition comprising said blood serum product as well as uses thereof in the treatment of various diseases and conditions, including epileptic seizures and apoplexy.
PCT/EP2004/014510 2003-12-18 2004-12-20 Biological active blood serum obtained by electrostimulation Ceased WO2005058889A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CA002546979A CA2546979A1 (en) 2003-12-18 2004-12-20 A biological active blood serum, methods of producing it and uses thereof
CN2004800376828A CN1893961B (en) 2003-12-18 2004-12-20 Bioactive serum obtained by electrical stimulation
US10/581,420 US20070110817A1 (en) 2004-10-18 2004-12-20 Biological active blood serum obtained by electrostimulation
JP2006544384A JP2007514706A (en) 2003-12-18 2004-12-20 Biologically active serum, method for its production and use
EP04804108A EP1699470A2 (en) 2003-12-18 2004-12-20 Biological active blood serum obtained by electrostimulation
BRPI0417797-5A BRPI0417797A (en) 2003-12-18 2004-12-20 biologically active blood serum, methods for producing it and its uses
AU2004299279A AU2004299279B2 (en) 2003-12-18 2004-12-20 Biological active blood serum obtained by electrostimulation
IL176343A IL176343A0 (en) 2003-12-18 2006-06-15 Biological active blood serum obtained by electrostimulation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/EP2003/014578 WO2005058333A1 (en) 2003-12-18 2003-12-18 Method for obtaining a biologically active blood serum treated with electroshock and the utilization thereof
EPPCT/EP03/14578 2003-12-18
US61973804P 2004-10-18 2004-10-18
US60/619,738 2004-10-18

Publications (2)

Publication Number Publication Date
WO2005058889A2 WO2005058889A2 (en) 2005-06-30
WO2005058889A3 true WO2005058889A3 (en) 2005-08-04

Family

ID=37873237

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/014510 Ceased WO2005058889A2 (en) 2003-12-18 2004-12-20 Biological active blood serum obtained by electrostimulation

Country Status (7)

Country Link
EP (1) EP1699470A2 (en)
JP (1) JP2007514706A (en)
AU (1) AU2004299279B2 (en)
BR (1) BRPI0417797A (en)
CA (1) CA2546979A1 (en)
RU (1) RU2364404C2 (en)
WO (1) WO2005058889A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1714659A1 (en) 2005-04-18 2006-10-25 OWEN Holding LTD A biological active blood serum for the treatment of stroke
EP1797890A1 (en) * 2005-12-09 2007-06-20 OWEN Holding LTD A method for obtaining a biologically active fraction of blood serum treated with gamma irradiation and the use thereof
RU2426548C2 (en) * 2009-02-13 2011-08-20 Виталий Александрович Шестаков Pharmaceutical composition and method of obtaining antioncologic fractions of blood serum (af bs)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001089455A2 (en) * 2000-05-22 2001-11-29 Merck & Company, Inc. System and method for assessing the performance of a pharmaceutical agent delivery system
EP1283047A1 (en) * 2000-02-29 2003-02-12 Vitaly Alexandrovich Shestakov Method for producing a bioactive substance from blood serum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
SU1015894A1 (en) * 1981-06-25 1983-05-07 Ордена Трудового Красного Знамени Научно-Исследовательский Институт Эпидемиологии И Микробиологии Им.Н.Ф.Гамалеи Method of producing blood embryonal serum
RU2120301C1 (en) * 1996-06-19 1998-10-20 Шестаков Виталий Александрович Method of preparing the biologically active blood serum

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1283047A1 (en) * 2000-02-29 2003-02-12 Vitaly Alexandrovich Shestakov Method for producing a bioactive substance from blood serum
WO2001089455A2 (en) * 2000-05-22 2001-11-29 Merck & Company, Inc. System and method for assessing the performance of a pharmaceutical agent delivery system

Also Published As

Publication number Publication date
AU2004299279A1 (en) 2005-06-30
RU2364404C2 (en) 2009-08-20
AU2004299279B2 (en) 2010-04-08
BRPI0417797A (en) 2007-03-20
RU2006121488A (en) 2007-12-27
CA2546979A1 (en) 2005-06-30
EP1699470A2 (en) 2006-09-13
WO2005058889A2 (en) 2005-06-30
JP2007514706A (en) 2007-06-07

Similar Documents

Publication Publication Date Title
EP2256201A3 (en) Modulation of eIF4E expression
EP1878725A3 (en) Pyrimidine derivatives and their use as CB2 modulators
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO2003018751A3 (en) Apparatus and method for electroporation of biological samples
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
EA200602191A1 (en) 5.5-DESIGNED-2-AMINO-4-THIAZOLIDINONES AND METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
WO2005016867A3 (en) Anthranilic acid derivatives and their use as activators of the hm74a receptor
EP1594885B8 (en) Medicament for inhibiting tumour growth
WO2004075815A3 (en) Diarylcycloalkyl derivatives, method for their production and their use as medicaments
WO2004087700A8 (en) Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
WO2004048522A3 (en) Modulation of huntingtin interacting protein 2 expression
WO2008023003A8 (en) Drug combinations for treating airway diseases
UA86399C2 (en) Normal;heading 1;heading 2;USE OF 2,5-DIHYDROXYBENZENESULPHONIC ACID IN THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF ANGIODEPENDENT DISEASES
WO2005058889A3 (en) Biological active blood serum obtained by electrostimulation
WO2004043394A3 (en) Modulation of huntingtin interacting protein 1 expression
WO2006041409A8 (en) Medical solution, method for producing and use thereof
WO2008009868A3 (en) Methods and tools for the therapy of neurodegenerative pathologies
TW200505830A (en) Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
WO2005123651A8 (en) L-2-(α-HYDROXYPENTYL)BENZOATES, THE PREPARATION AND THE USE THEREOF
DE10394363D2 (en) New chelidonine derivatives, process for their preparation and their use for the preparation of pharmaceutical active ingredients
WO2004076414A3 (en) Novel compounds
WO2005082884A3 (en) 2-pyridin-2yl-pyrimidine derivatives useful in the treatment of gastro-esophagea l reflux disease
WO2005021541A3 (en) Process for the production of polymorphs of rosiglitazone maleate

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480037682.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004804108

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004299279

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2868/DELNP/2006

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2546979

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2004299279

Country of ref document: AU

Date of ref document: 20041220

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004299279

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 176343

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2006544384

Country of ref document: JP

Ref document number: 2006121488

Country of ref document: RU

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWP Wipo information: published in national office

Ref document number: 2004804108

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007110817

Country of ref document: US

Ref document number: 10581420

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0417797

Country of ref document: BR

WWP Wipo information: published in national office

Ref document number: 10581420

Country of ref document: US